Japanese researchers find diabetes drugs’ potential to protect kidneys
A team of Japanese researchers has found a class of diabetes drugs that help the kidneys to flush out glucose and maintain kidney health.
Discover Patanjali’s Madhugrit, an Ayurvedic diabetes solution blending natural herbs with scientific research to manage blood sugar and enhance well-being.
With diabetes impacting millions worldwide, the search for effective, holistic treatment methods is intensifying. Patanjali, a leader in Ayurvedic health solutions, has made strides in combining traditional wisdom with modern scientific research to offer evidence-based therapies for diabetes management. Their innovation, Madhugrit, positions itself as a natural alternative to conventional medications.
Madhugrit is an Ayurvedic tablet prepared from 29 herbs and minerals, which have reportedly been anti-diabetic in action. The most important ingredients of bitter gourd, fenugreek, neem, and cinnamon prevent the increase of blood sugar levels or inflammation while improving metabolic functions.
According to preclinical tests, it can control glucose levels and be safe for the pancreas. According to one research, it had even gone ahead of metformin, an allopathic drug commonly used, in significant performance indicators.
Advertisement
डायबिटीज के लिए रिसर्च एंड एविडेंस बेस्ड ट्रीटमेंट #Diabetes #PatanjaliResearchInstitute pic.twitter.com/AZ0SbQGyyI
— स्वामी रामदेव (@yogrishiramdev) November 9, 2024
This product has undergone testing through clinical studies involving 150 participants. It is therefore likely to significantly increase the fasting blood sugar and energy levels in patients. The experiment also indicated a possibility of an influence on complications such as neuropathy and fatigue associated with diabetes.
Patanjali has also mentioned that control over diabetes is not possible by just Madhugrit. This approach involves yogic and pranayama exercises along with dietetic approach individualized for a patient from Ayurveda that proves helpful by increasing the sensitivity towards insulin, reducing the tension, and re-establishing the natural balance in the body. Hence, it is complete and patient-oriented treatment.
These would include asanas such as Paschimottanasana and Dhanurasana, which increase the efficiency of the pancreas, kapalbhati pranayama, which increases the metabolic rate, and such other lifestyles along with dietary advice, including low glycemic foods and natural remedies. Thus, Patanjali has to offer a lifestyle transformation in managing diabetes.
India is rapidly becoming the diabetes capital of the world, with about 11 percent of its adult population diagnosed with the disease. About 15 percent of them are pre-diabetic, and the alarming levels of awareness are still low. Traditional treatments remain effective but come with side effects and dependency; this has made most patients seek complementary therapies like Ayurveda.
According to the founder of this company, Acharya Balkrishna, it is an idea of sustainable solutions for health based on available and affordable principles, natural in this growing health crisis. Combining the therapeutic potential of Ayurveda with stern scientific validation, the company aimed to become a bridge between traditional and modern medicine.
But doctors and health care professionals are cautious of the preliminary results from the study of Patanjali. Ayurvedic treatments should be supplemented only after consulting the medical experts. Diabetes may be a condition of complexities in forms of treatments, and each patient should ensure that the new treatment can dovetail with the system of medications and health goals.
In a nutshell, Madhugrit by Patanjali is a significant stride toward incorporating Ayurveda into mainstream diabetes management. It has an evidence-based underpinning and forms a holistic philosophy in offering a ray of hope to those seeking natural means to manage this chronic condition effectively.
Advertisement